Drug companies have agreed to about $260 billion of deals so far in 2014, the most since at least 2002 and more than twice the volume last year, according to data compiled by Bloomberg.
Bloomberg didn’t explain what all these deals mean for people like you and me, but I don’t think all this M&A activity will prove to be good for the average consumer.
All Things Chronic 